| Code | 1909F | ||||||||||
| MA number | 44/0392/25-S | ||||||||||
| Product Form: | cps dur 90x4 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Pharmevid s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 20.11.2025 |
| Validity: | 20.11.2030 |
| Pediatric posology: | Yes |
| SPC: |
SPC_Lenvatinib Pharmevid 4 mg, 10 mg_cps dur_11/2025_REG.pdf
|
| PIL: |
PIL_Lenvatinib Pharmevid 4 mg, 10 mg_cps dur_11/2025_REG.pdf
|
| Safety feature | Yes |
| Data update: | 26.11.2025 |
